So a compounding pharmacy can put together drugs, but they don't have to come to the FDA to ask approval or even register with you to let you know that they are doing that, isn't that correct?
Henry Waxman
The Public Record
Henry Waxman is a former U.S. Representative from California, serving from 1975 to 2015. A member of the Democratic Party, he was known for his work on health care, environmental policy, and consumer protection. During his tenure, Waxman played a key role in the passage of the Affordable Care Act and was a prominent advocate for climate change legislation. He chaired the House Energy and Commerce Committee, where he focused on issues such as tobacco regulation and health care reform.
This meningitis outbreak from compounded drugs has claimed the lives of over 50 people, sickened over 700, brought unspeakable grief upon hundreds of families, and it is one of our Nation's worst public health disasters in recent memory.
I think it is part of the reason that we have this bill, have somebody besides the EPA taking a look at these issues.
The whole idea of this bill is so that the EPA can take a look at it and say, OK, maybe we need to find a less costly way of doing this if it is a good thing to do.
This is a bill that we shouldn't be spending our time talking about because it just doesn't make sense even though we are being told it is common sense.
As Congressman Waxman explained in his opening statement, the ratio between the cost and the benefits, the benefits exceed the cost by several orders of magnitude in almost all of these rules.
Mr. Chairman, the American people want us to solve their problems, not waste our time with partisan posturing.
Faced with these facts, opponents of EPA rules now argue that we should simply ignore the benefits and consider only the costs.
This bill sets a different standard for critical public health and environmental standards to be determined under law by the Environmental Protection Agency.
So it is imperative that we allow the EPA to act as an impartial referee and ensure that the playing field is level for all Americans.
This bill relies on an outlandish premise: that EPA's public health and environmental protections provide no benefits at all to the American people.
Chairman, the American people want us to solve problems not waste our time with partisan posturing, taking up nonsensical message bills that stand no chance of becoming law.
If I just looked at the costs, that would be one way to make a decision, but you should look at the costs and benefits.
The discussion draft is hopelessly flawed. It gives the Department of Energy (DOE) a veto over EPA regulations.
That would require rethinking this legislation and listening to the expert views available to us.
I continue to oppose such an approach and believe that there is simply not the support for this proposal to be become law.





